Unprofitable Large Caps

Companies valued over $1B that are still burning cash. Pre-profit growth stories, turnaround plays, or value traps — proceed with caution.

200 stocks Updated Mar 26, 2026
$21.44T Total Market Cap
$57.20 Avg Share Price
+1.20% Avg Daily Change
$5.10 – $677.86 Price Range

Not every large company is profitable. This list tracks companies with market caps above $1 billion that are currently losing money — their earnings per share (EPS) is negative. These firms span the spectrum from high-growth businesses investing aggressively to reach scale, to struggling companies in turnaround mode, to declining businesses burning through remaining cash.

Some of the market's biggest winners started as money-losers. Amazon reported losses for years while building its e-commerce and cloud infrastructure. Tesla lost money for over a decade before achieving sustained profitability. Today's unprofitable companies in biotech, EVs, and SaaS may follow similar paths — or they may never turn profitable. Separating the future winners from the permanent losers requires deep fundamental analysis.

This list shows the EPS (negative), daily change, volume, and market cap for each unprofitable company. Stocks are sorted by the magnitude of their losses. Use this list to identify potential turnaround candidates or to screen out companies that do not meet profitability requirements.

# Symbol Name Price EPS Change % Volume Market Cap
1 SATS Echostar Corp-A $119.07 $-50.33 +7.43% 30.64B
2 MAAS Maase Inc-A $5.57 $-46.89 -0.89% 1.92B
3 SONY Sony Group Corporation $20.66 $-37.08 +0.44% 19.99T
4 SBET Sharplink Inc $7.28 $-28.55 +1.53% 1.45B
5 CAR Avis Budget Group Inc $123.56 $-25.34 +5.17% 3.44B
6 TTWO Take-Two Interactive Softwre $193.05 $-22.36 +0.88% 37.17B
7 ENOV Enovis Corp $21.85 $-20.72 -3.19% 1.40B
8 CNXC Concentrix Corp $26.48 $-20.67 -19.85% 1.99B
9 TFX Teleflex Inc $108.18 $-20.56 +1.52% 4.66B
10 LBRDK Liberty Broadband-C $50.94 $-18.71 +0.63% 7.12B
11 LBRDA Liberty Broadband-A $50.92 $-18.71 +0.61% 7.12B
12 FMC Fmc Corp $14.23 $-17.88 +8.71% 1.75B
13 MSTR Strategy Inc $139.13 $-17.25 +2.11% 35.81B
14 QDEL Quidelortho Corp $15.24 $-16.66 -8.03% 1.04B
15 FUN Six Flags Entertainment Corp $17.42 $-15.87 +2.23% 1.78B
16 TBBB Bbb Foods Inc-Class A $34.58 $-15.80 -0.86% 3.81B
17 BBUC Brookfield Business-Cl A $32.54 $-15.09 +6.55% 4.06B
18 ASH Ashland Inc $53.61 $-15.01 +5.51% 2.63B
19 CNC Centene Corp $32.73 $-13.62 -0.76% 21.48B
20 DLTR Dollar Tree Inc $106.64 $-13.48 +0.10% 22.82B
21 PRAX Praxis Precision Medicines I $311.92 $-12.90 +5.86% 9.09B
22 MDGL Madrigal Pharmaceuticals Inc $461.93 $-12.85 +3.80% 10.08B
23 ZBIO Zenas Biopharma Inc $22.30 $-12.67 -4.58% 1.35B
24 HNGE Hinge Health Inc-A $40.91 $-12.53 -2.85% 3.30B
25 ACHC Acadia Healthcare Co Inc $22.73 $-12.20 -1.00% 2.36B
26 GLTO Galecto Inc $23.05 $-12.01 +27.07% 1.73B
27 WFG West Fraser Timber Co Ltd $64.05 $-11.96 +1.43% 6.54B
28 SJM Jm Smucker Co/The $95.39 $-11.79 -1.52% 11.86B
29 WLK Westlake Corp $114.22 $-11.76 +0.11% 13.40B
30 GRAL Grail Inc $52.29 $-11.63 +7.48% 3.96B
31 RAPT Rapt Therapeutics Inc $58.02 $-11.08 +0.07% 1.60B
32 WKC World Kinect Corp $23.09 $-11.06 +0.52% 1.16B
33 RAL Ralliant Corp $42.78 $-10.84 +0.47% 4.93B
34 TAP Molson Coors Beverage Co - B $41.27 $-10.68 +0.27% 9.58B
35 CE Celanese Corp $62.66 $-10.61 +3.06% 6.01B
36 PRGO Perrigo Co Plc $9.25 $-10.36 -4.15% 1.28B
37 VAC Marriott Vacations World $70.12 $-9.49 -0.44% 2.32B
38 GLIBA Gci Liberty Inc-Cl A $36.80 $-8.89 -0.03% 1.60B
39 GLIBK Gci Liberty Inc-Cl C $36.79 $-8.89 -0.03% 1.60B
40 LCID Lucid Group Inc $10.68 $-8.62 +3.09% 3.38B
41 SRPT Sarepta Therapeutics Inc $17.62 $-8.48 -0.51% 1.82B
42 PII Polaris Inc $56.81 $-8.18 +0.25% 3.70B
43 STLA Stellantis Nv $6.88 $-7.75 +1.93% 20.97B
44 BHVN Biohaven Ltd $8.39 $-7.60 -4.00% 1.65B
45 SNDK Sandisk Corp $677.86 $-7.59 -3.50% 82.22B
46 NKTR Nektar Therapeutics $72.22 $-7.58 -3.50% 1.98B
47 CHYM Chime Financial Inc-Cl A $17.70 $-7.52 -4.48% 7.13B
48 MRNA Moderna Inc $53.54 $-7.26 +4.29% 19.42B
49 NIO NIO Inc $5.84 $-7.06 +1.92% 12.61B
50 AGIO Agios Pharmaceuticals Inc $27.53 $-6.96 -2.06% 1.70B
51 STEP Stepstone Group Inc-Class A $47.79 $-6.95 +0.95% 5.62B
52 SEDG Solaredge Technologies Inc $51.73 $-6.88 +13.29% 3.12B
53 IP International Paper Co $36.47 $-6.70 +0.91% 20.93B
54 CYTK Cytokinetics Inc $62.39 $-6.53 +3.95% 7.60B
55 CRSP Crispr Therapeutics Ag $47.09 $-6.51 +1.42% 4.66B
56 ARX Accelerant Holdings-Cl A $12.95 $-6.47 +6.32% 2.33B
57 LBTYB Liberty Global Ltd-B $13.01 $-6.43 -5.31% 4.08B
58 LBTYA Liberty Global Ltd-A $12.28 $-6.43 +0.90% 4.08B
59 LBTYK Liberty Global Ltd-C $11.98 $-6.43 +0.25% 4.08B
60 INSM Insmed Inc $148.31 $-6.40 +6.59% 30.09B
61 OC Owens Corning $107.97 $-6.40 +0.99% 8.82B
62 BEPC Brookfield Renewable Corp $39.82 $-6.27 +1.25% 6.15B
63 JAZZ Jazz Pharmaceuticals Plc $189.08 $-6.07 +2.20% 10.27B
64 PENN Penn Entertainment Inc $14.70 $-6.02 +1.59% 1.95B
65 GT Goodyear Tire & Rubber Co $6.45 $-5.99 +1.10% 2.04B
66 IRON Disc Medicine Inc $62.55 $-5.98 +4.93% 2.30B
67 NUVL Nuvalent Inc-A $98.00 $-5.85 +1.92% 7.63B
68 RARE Ultragenyx Pharmaceutical In $19.87 $-5.84 -2.69% 2.19B
69 MIDD Middleby Corp $136.99 $-5.73 +0.65% 6.38B
70 PCVX Vaxcyte Inc $55.91 $-5.63 +2.27% 7.77B
71 NX Quanex Building Products $17.71 $-5.49 +2.61% 1.01B
72 EXAS Exact Sciences Corp $104.91 $-5.32 +0.95% 19.73B
73 BLSH Bullish $37.43 $-5.07 +0.16% 5.21B
74 BCAX Bicara Therapeutics Inc $18.22 $-5.03 -0.92% 1.19B
75 KHC Kraft Heinz Co/The $21.51 $-4.94 +0.89% 25.76B
76 CRNX Crinetics Pharmaceuticals In $36.34 $-4.94 +5.73% 3.90B
77 THS Treehouse Foods Inc $24.43 $-4.83 -0.08% 1.23B
78 AXSM Axsome Therapeutics Inc $161.78 $-4.66 +1.91% 9.39B
79 VERA Vera Therapeutics Inc $40.16 $-4.66 +1.03% 2.91B
80 LSPD Lightspeed Commerce Inc $8.96 $-4.62 +2.17% 1.75B
81 EQH Equitable Holdings Inc $38.19 $-4.61 +1.65% 10.44B
82 EOSE Eos Energy Enterprises Inc $5.10 $-4.46 +0.20% 3.71B
83 AVBP Arrivent Biopharma Inc $22.18 $-4.46 +0.73% 1.01B
84 BEAM Beam Therapeutics Inc $24.63 $-4.43 -2.15% 2.83B
85 XRAY Dentsply Sirona Inc $11.47 $-4.43 -0.65% 2.73B
86 QURE Uniqure Nv $16.09 $-4.39 +5.44% 1.45B
87 APGE Apogee Therapeutics Inc $78.53 $-4.36 +7.58% 5.05B
88 STUB Stubhub Holdings Inc-Class A $6.87 $-4.36 +4.25% 2.47B
89 XENE Xenon Pharmaceuticals Inc $55.57 $-4.36 +4.10% 4.98B
90 ALB Albemarle Corp $181.39 $-4.34 +2.45% 19.79B
91 REZI Resideo Technologies Inc $35.63 $-4.33 +1.19% 5.41B
92 CPRI Capri Holdings Ltd $18.09 $-4.26 -2.43% 2.54B
93 VET Vermilion Energy Inc $13.89 $-4.26 -3.68% 3.03B
94 RNA Avidity Biosciences Inc $13.09 $-4.17 -0.83% 2.25B
95 MARA Mara Holdings Inc $8.28 $-4.16 +0.36% 3.51B
96 KOD Kodiak Sciences Inc $22.75 $-4.12 +4.12% 1.38B
97 DNTH Dianthus Therapeutics Inc $78.55 $-4.11 -0.97% 3.56B
98 SNOW Snowflake Inc. $160.61 $-4.04 -0.45% 61.32B
99 LIVN Livanova Plc $63.30 $-4.01 +1.44% 3.71B
100 UCTT Ultra Clean Holdings Inc $57.67 $-4.01 -7.92% 2.70B

Frequently Asked Questions

Why do some large companies lose money?
Companies lose money for several reasons: they may be investing heavily in growth (R&D, customer acquisition, infrastructure), experiencing temporary business disruptions, executing turnaround strategies after management changes, or operating in cyclical industries during downturns. Some unprofitable companies are pre-revenue biotech firms burning cash on drug development. Others are mature companies whose business models are being disrupted by new competitors or technology.
Can unprofitable stocks be good investments?
Yes, but with significant risk. Amazon and Tesla were both unprofitable for years and rewarded patient investors enormously. The key is evaluating whether losses are strategic investments in future profitability (positive) or signs of a broken business model (negative). Look for growing revenue, improving margins, and a clear path to breakeven. Companies burning cash with no revenue growth and no margin improvement are unlikely to recover.
What is cash burn rate?
Cash burn rate measures how quickly a company spends its cash reserves. If a company has $500 million in cash and burns $50 million per quarter, it has roughly 10 quarters (2.5 years) of runway. Cash burn is critical for evaluating unprofitable companies because it shows how long they can survive before needing to raise additional capital. Companies that must raise money through stock issuance dilute existing shareholders.
What sectors have the most unprofitable companies?
Biotechnology leads by far — most biotech companies are pre-revenue, spending years and billions on drug development before a product reaches market. Technology and software companies may be unprofitable while investing in customer growth and platform development. Electric vehicle and clean energy companies often operate at losses during their ramp-up phase. Cyclical industries like mining and oil can show temporary losses during commodity downturns.
What is the path to profitability?
The path to profitability describes how a loss-making company plans to achieve positive earnings. Key elements include revenue growth (more sales to absorb fixed costs), margin expansion (improving efficiency), and operating leverage (fixed costs spread over growing revenue). Management typically outlines this path during earnings calls and investor presentations. Companies with visible paths to profitability — where improvements are measurable quarter-over-quarter — are more attractive than those with vague promises.
Should I avoid all unprofitable stocks?
Not necessarily. Avoiding all unprofitable stocks would have meant missing Amazon, Tesla, and many biotech winners. However, most unprofitable stocks do underperform the market over time. A reasonable approach is to limit unprofitable positions to a small percentage of your portfolio (5-15%), focus on companies with strong revenue growth and improving margins, and be prepared for higher volatility. Use profitability as a quality screen for the core of your portfolio.
What is operating leverage?
Operating leverage describes how a company's fixed costs amplify profitability as revenue grows. A software company with $100 million in fixed costs loses money at $80 million revenue but earns $20 million at $120 million revenue — the costs did not change, but revenue surpassed them. Companies with high operating leverage can transition from unprofitable to very profitable quickly once revenue hits the breakeven point. This is why many SaaS and platform companies eventually achieve high profit margins.

More Stock Lists